BRAFVal600 phosphorylates and activates Mitogen-activated protein kinase kinase 1 (MEK1) and MEK2, which in turn phosphorylate and activate ERK1/2, stimulating the MAPK pathway and ultimately promoting tumor growth. The gene discussed is MAP2K1; the disease is neoplasm.